EWTX8:00 AMEdgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rulesedgewisetx.com
EWTX7:00 AMEdgewise Therapeutics Unveils the Differentiated Mechanism of Action (MoA) of its Cardiac Sarcomere Modulator EDG-7500edgewisetx.com
EWTX8:00 AMEdgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rulesedgewisetx.com
EWTX8:00 AMEdgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026edgewisetx.com